Annual CFI
-$5.41 M
+$337.00 K+5.86%
31 December 2023
Summary:
Barinthus Biotherapeutics annual cash flow from investing activities is currently -$5.41 million, with the most recent change of +$337.00 thousand (+5.86%) on 31 December 2023. During the last 3 years, it has fallen by -$5.12 million (-1747.44%). BRNS annual CFI is now -1747.44% below its all-time high of -$293.00 thousand, reached on 01 December 2020.BRNS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$114.00 K
+$78.00 K+40.63%
30 September 2024
Summary:
Barinthus Biotherapeutics quarterly cash flow from investing activities is currently -$114.00 thousand, with the most recent change of +$78.00 thousand (+40.63%) on 30 September 2024. Over the past year, it has dropped by -$78.00 thousand (-216.67%). BRNS quarterly CFI is now -174.51% below its all-time high of $153.00 thousand, reached on 31 December 2023.BRNS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$461.00 K
-$78.00 K-20.37%
30 September 2024
Summary:
Barinthus Biotherapeutics TTM cash flow from investing activities is currently -$461.00 thousand, with the most recent change of -$78.00 thousand (-20.37%) on 30 September 2024. Over the past year, it has increased by +$5.69 million (+92.51%). BRNS TTM CFI is now -1995.45% below its all-time high of -$22.00 thousand, reached on 01 March 2020.BRNS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BRNS Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.9% | -216.7% | +92.5% |
| 3 y3 years | -1747.4% | +10.9% | +49.7% |
| 5 y5 years | - | - | - |
BRNS Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1747.4% | +58.1% | -174.5% | +99.1% | -20.4% | +97.3% |
| 5 y | 5 years | -1747.4% | +58.1% | -174.5% | +99.1% | -1995.5% | +97.3% |
| alltime | all time | -1747.4% | +58.1% | -174.5% | +99.1% | -1995.5% | +97.3% |
Barinthus Biotherapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$114.00 K(-40.6%) | -$461.00 K(+20.4%) |
| June 2024 | - | -$192.00 K(-37.7%) | -$383.00 K(-88.1%) |
| Mar 2024 | - | -$308.00 K(-301.3%) | -$3.21 M(-40.6%) |
| Dec 2023 | -$5.41 M(-5.9%) | $153.00 K(-525.0%) | -$5.41 M(-12.0%) |
| Sept 2023 | - | -$36.00 K(-98.8%) | -$6.15 M(-24.4%) |
| June 2023 | - | -$3.02 M(+20.6%) | -$8.13 M(+13.5%) |
| Mar 2023 | - | -$2.51 M(+327.8%) | -$7.17 M(+24.6%) |
| Dec 2022 | -$5.75 M | -$586.00 K(-71.0%) | -$5.75 M(-66.9%) |
| Sept 2022 | - | -$2.02 M(-1.8%) | -$17.35 M(+12.2%) |
| June 2022 | - | -$2.05 M(+88.1%) | -$15.46 M(+13.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$1.09 M(-91.0%) | -$13.61 M(+5.4%) |
| Dec 2021 | -$12.91 M(+4306.8%) | - | - |
| Dec 2021 | - | -$12.19 M(+9423.4%) | -$12.91 M(+1308.1%) |
| Sept 2021 | - | -$128.00 K(-36.6%) | -$917.00 K(+12.0%) |
| June 2021 | - | -$202.00 K(-48.5%) | -$819.00 K(+23.5%) |
| Mar 2021 | - | -$392.00 K(+101.0%) | -$663.00 K(+126.3%) |
| Dec 2020 | -$293.00 K | -$195.00 K(+550.0%) | -$293.00 K(+199.0%) |
| Sept 2020 | - | -$30.00 K(-34.8%) | -$98.00 K(+44.1%) |
| June 2020 | - | -$46.00 K(+109.1%) | -$68.00 K(+209.1%) |
| Mar 2020 | - | -$22.00 K | -$22.00 K |
FAQ
- What is Barinthus Biotherapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual CFI year-on-year change?
- What is Barinthus Biotherapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics quarterly CFI year-on-year change?
- What is Barinthus Biotherapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics TTM CFI year-on-year change?
What is Barinthus Biotherapeutics annual cash flow from investing activities?
The current annual CFI of BRNS is -$5.41 M
What is the all time high annual CFI for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual cash flow from investing activities is -$293.00 K
What is Barinthus Biotherapeutics annual CFI year-on-year change?
Over the past year, BRNS annual cash flow from investing activities has changed by +$337.00 K (+5.86%)
What is Barinthus Biotherapeutics quarterly cash flow from investing activities?
The current quarterly CFI of BRNS is -$114.00 K
What is the all time high quarterly CFI for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly cash flow from investing activities is $153.00 K
What is Barinthus Biotherapeutics quarterly CFI year-on-year change?
Over the past year, BRNS quarterly cash flow from investing activities has changed by -$78.00 K (-216.67%)
What is Barinthus Biotherapeutics TTM cash flow from investing activities?
The current TTM CFI of BRNS is -$461.00 K
What is the all time high TTM CFI for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high TTM cash flow from investing activities is -$22.00 K
What is Barinthus Biotherapeutics TTM CFI year-on-year change?
Over the past year, BRNS TTM cash flow from investing activities has changed by +$5.69 M (+92.51%)